NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
NPCE is expected to report earnings to rise 6.76% to -22 cents per share on August 12
Q2'25
Est.
$-0.22
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.07
Q3'24
Beat
by $0.08
Q2'24
Beat
by $0.04
The last earnings report on May 13 showed earnings per share of -20 cents, beating the estimate of -23 cents. With 137.06K shares outstanding, the current market capitalization sits at 294.53M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NPCE showed earnings on May 13, 2025. You can read more about the earnings report here.